Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients [clinicaltrials:NCT01062659]
Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients [clinicaltrials:NCT01062659]
Bio2RDF identifier
NCT01062659
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT01062659
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
arm group [clinicaltrials_vocabulary:arm-group]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
In order to persist in ...... sponse to IFNα / RBV therapy.
brief title [clinicaltrials_vocabulary:brief-title]
Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients
completion date [clinicaltrials_vocabulary:completion-date]
2013-03-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2010-02-03T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
Anti-Infective Agents
Hepatitis, Viral, Human
chronic hepatitis c
hepatitis C virus
interferon
peginterferon alfa-2a
peginterferon alfa-2b
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2014-03-31T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT01062659
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Characterization of Cellular I ...... ic Hepatitis C Virus Infection
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2012-12-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2010-02-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2014-03-01T00:00:00Z
why stopped [clinicaltrials_vocabulary:why-stopped]
Lack of funding
identifier
clinicaltrials:NCT01062659
title
Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients
@en
type
label
Cellular Immune Responses in t ...... s [clinicaltrials:NCT01062659]
@en